Indian pharma industry is capable of delivering 100 new drugs by 2047 for global markets backed by enhanced research and ...

Speaking at an event, he stressed the need for innovation, capability building, and a focus on societal benefit.

Zydus Lifesciences Chairman Pankaj R Patel believes India can deliver 100 new drugs by 2047, emphasizing the need for ...

Pankaj R Patel, Chairman of Zydus Lifesciences, envisions India delivering 100 new drugs by 2047, highlighting the importance of research, innovation, and capable human resources. He addressed myths ...

Indian markets closed lower on Thursday, dragged by banking and auto stocks, while U.S. tariff concerns pressured sentiment.

The Nifty Pharma index closed on a negative note on Thursday. Shares of Ipca Laboratories Ltd.(up 1.97 per cent), Gland ...

Retail and banking stocks rose 0.5 per cent and 0.7 per cent, respectively. NEW DELHI: BSE(Rs. 2851.95 crore), HDFC Bank(Rs.

Indian drugmakers prepare for US tariffs, emphasizing role in providing affordable medicines while navigating potential impacts and uncertainties.

Mumbai: Piramal Pharma has announced that the Company has received six observations from US Food and Drug Administration ...

Piramal Pharma slipped 1.14% to Rs 195.40 after the US FDA issued a Form-483 with 6 observations to the company's Turbhe facility post a GMP inspection.

Piramal Pharma shares will be in focus after the US FDA's GMP inspection at its Turbhe facility from February 11-17, 2025, ...

The company's Q3FY25 consolidated profit plunged 63.6 percent to Rs 3.68 crore versus Rs 10.1 crore, while revenue rose 12.5 ...